A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use disorder is being honored with a 2025 Top Ten Clinical Research Achievement Award.
A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established, according to a recent paper.